The history of the United States Congress is punctuated by trading scandals that have eroded public trust, prompted legislative reform, and in rare cases led to criminal convictions. While the STOCK Act of 2012 was supposed to bring transparency and accountability to congressional financial activity, the scandals have continued — and in some ways, intensified.
This article examines the most significant congressional trading scandals in history, the patterns that connect them, and what they reveal about the gap between disclosure rules and actual enforcement.
The COVID-19 Trading Scandal (2020)
The most high-profile congressional trading controversy of the modern era began in January 2020, when members of Congress received classified briefings from public health officials about the emerging coronavirus threat. While publicly downplaying the risk, several senators made significant changes to their stock portfolios that appeared designed to protect their wealth from the market crash that was about to unfold.
Senator Richard Burr (R-NC) sold between $628,000 and $1.72 million in stocks on February 13, 2020, just one week before the market began its steep decline. As chairman of the Senate Intelligence Committee, Burr had received detailed briefings about the potential severity of the pandemic. He dumped shares in hotel and travel companies that would be devastated by lockdowns. The FBI seized his cell phone as part of an investigation, and he stepped down as Intelligence Committee chairman. The DOJ ultimately declined to bring charges, but the episode became a symbol of congressional self-dealing.
Senator Kelly Loeffler (R-GA) and her husband, Jeffrey Sprecher — who is the chairman of the New York Stock Exchange — sold millions of dollars in stock starting on January 24, 2020, the same day Loeffler attended a private Senate Health Committee briefing on the coronavirus. They also purchased shares in Citrix, a company that makes remote-work technology that would benefit from lockdowns. Loeffler denied any wrongdoing and said her trades were handled by third-party advisors.
Senator Dianne Feinstein (D-CA) sold $1.5 million to $6 million in stock in a biotech company through her husband on January 31, 2020. She stated that she was not involved in the trading decisions and that her assets were managed in a blind trust. The DOJ investigated and declined to pursue charges.
Senator Jim Inhofe (R-OK) sold up to $400,000 in stock in late January 2020. He maintained that the trades were part of a pre-planned divestiture strategy and that he had directed his broker to sell the stocks before the briefing. The investigation into his trades was also closed without charges.
For a detailed examination of the timeline, investigations, and outcomes, see our dedicated article on the COVID-19 congressional trading scandal.
Nancy Pelosi and the Rise of the "Pelosi Tracker"
While not a scandal in the legal sense, the trading activity of Nancy Pelosi's household became one of the most talked-about congressional trading stories of the 2020s. Her husband, Paul Pelosi, made a series of large, well-timed trades in major tech companies — including NVIDIA, Alphabet (Google), Apple, and others — that consistently outperformed the broader market.
The trades drew scrutiny because of Nancy Pelosi's position as Speaker of the House and her influence over legislation affecting the tech sector, including antitrust bills, semiconductor subsidies (the CHIPS Act), and data privacy regulation. Critics argued that Paul Pelosi's trades, particularly his significant purchases of NVIDIA call options before the AI-driven stock surge and his Google purchases ahead of antitrust decisions, suggested access to non-public information.
The phenomenon spawned a cottage industry of "Pelosi trackers" — social media accounts, newsletters, and tools dedicated to following her household's trades and attempting to replicate them. The story made congressional trading a mainstream cultural topic, reaching audiences on TikTok and Reddit who had never previously paid attention to financial disclosure filings. For a full analysis, see our Pelosi trading explainer.
Chris Collins: The Only Convicted Insider Trader in Congress
Representative Chris Collins (R-NY) holds the distinction of being the only sitting member of Congress to be convicted of insider trading. In June 2017, Collins was attending a congressional picnic at the White House when he received an email informing him that a drug trial for Innate Immunotherapeutics, an Australian biotech company on whose board Collins sat, had failed.
Collins immediately called his son, Cameron Collins, who sold his shares before the news became public. Cameron then tipped off others, who also sold. When the drug trial results were announced publicly, Innate Immunotherapeutics' stock price plummeted by 92 percent. Those who sold early avoided massive losses.
Collins was indicted in August 2018 on charges of securities fraud, wire fraud, and making false statements to the FBI. He initially denied the charges and won re-election in November 2018, but reversed course and pleaded guilty in October 2019. He was sentenced to 26 months in federal prison and ordered to pay a $200,000 fine. In January 2021, President Donald Trump pardoned Collins as part of a batch of pardons issued on his last day in office.
The Collins case is often cited as the exception that proves the rule: despite numerous instances of suspicious trading by members of Congress, it is extremely rare for a case to result in criminal charges, let alone a conviction.
The Duke Cunningham Bribery Scandal
While not a stock trading scandal in the traditional sense, the case of Representative Randy "Duke" Cunningham (R-CA) is relevant because it illustrates how members of Congress can exploit their positions for personal financial gain through channels beyond the stock market.
Cunningham, a member of the House Appropriations Committee and its Defense Subcommittee, accepted at least $2.4 million in bribes from defense contractors in exchange for steering government contracts their way. The bribes took the form of cash, a yacht (named the "Duke-Stir"), a Rolls-Royce, antiques, and payments on his mortgage.
Cunningham pleaded guilty in 2005 to federal charges of conspiracy to commit bribery, mail fraud, wire fraud, and tax evasion. He was sentenced to eight years and four months in prison — at the time, the longest sentence ever given to a former member of Congress. The scandal contributed to the Democratic wave in the 2006 midterm elections and renewed calls for ethics reform.
Historical Patterns and Earlier Cases
Congressional financial misconduct is not a modern invention. Throughout the 20th century, numerous members faced scrutiny for financial dealings that appeared to exploit their positions.
The 2011 60 Minutes investigation. A landmark segment revealed that multiple members of Congress had made trades that appeared timed to coincide with non-public legislative information. The segment featured examples from both parties and played a direct role in the passage of the STOCK Act the following year.
Senator Bob Menendez (D-NJ). While primarily charged with bribery rather than stock trading, Menendez's case illustrated the entanglement of financial interests and legislative power. He was indicted on federal bribery and fraud charges related to accepting gifts and campaign contributions in exchange for using his influence to benefit a wealthy donor.
The Keating Five (1989). Five senators — Alan Cranston, Dennis DeConcini, John Glenn, John McCain, and Donald Riegle — were accused of improperly intervening with federal regulators on behalf of Charles Keating, whose savings and loan institution later collapsed. While the senators held no stock in Keating's company, they had accepted substantial campaign contributions, and the scandal highlighted the broader problem of financial conflicts of interest in Congress.
Common Patterns Across Scandals
Looking at the full history of congressional trading controversies, several recurring patterns emerge:
- Committee membership matters. The most suspicious trades often involve members trading in sectors directly overseen by their committees. A member of the Senate Health Committee trading pharmaceutical stocks or a member of the House Armed Services Committee trading defense stocks raises obvious red flags.
- Disclosure delays reduce accountability. The 45-day reporting window under the STOCK Act means that trades can be hidden from public view for weeks, reducing the ability of journalists and watchdogs to identify suspicious patterns in real time. Many members file even later than 45 days with no meaningful consequences. You can see who files late on our late filers analysis page.
- Enforcement is weak. The DOJ has consistently declined to prosecute members of Congress for suspicious trading, except in the most egregious cases. The SEC has also been reluctant to pursue cases against sitting legislators. The result is a system where rules exist on paper but are rarely enforced in practice.
- Both parties are implicated. While individual scandals may center on one party, the broader pattern of congressional trading controversies spans the political spectrum. This is not a partisan issue — it is a structural one.
The Impact on Public Trust and Reform Efforts
Each scandal has contributed to declining trust in Congress and increased pressure for reform. The COVID-19 trades, in particular, generated bipartisan outrage that appeared to bring a trading ban closer to reality than ever before. Yet the legislative process has repeatedly stalled, with bills dying in committee or failing to reach the floor.
The growing availability of trading data through tools like CongressFlow's trade tracker has changed the dynamic by making it easier for the public to monitor congressional financial activity in near real time. The question is whether increased transparency will eventually force legislative action or whether the current system of disclosure without prohibition will persist.
For a broader look at the debate over whether Congress should be banned from trading stocks entirely, read our analysis of the congressional trading ban debate.
